Literature DB >> 2311184

DNA methyl-adduct dosimetry and O6-alkylguanine-DNA alkyl transferase activity determinations in rat mammary carcinogenesis by procarbazine and N-methylnitrosourea.

L Y Fong1, D E Jensen, P N Magee.   

Abstract

The metabolism of the carcinogenic antitumor drug procarbazine (PCZ) is complex with the ultimate production, among other metabolites, of a methyldiazonium ion which is also the ultimate carcinogenic species of the DNA-methylating N-nitroso compounds including N-methylnitrosourea (MNU). This suggests a similar mechanism of carcinogenic action. Following a single oral dose of [14C]PCZ (50 mg/rat) to 50 day old female Sprague-Dawley rats under the reported conditions of mammary gland carcinogenicity, the DNA adducts 7-methylguanine (7-meG) and O6-methylguanine (O6-meG) were determined in target (mammary gland) and non-target organs. The degree of DNA methylation was similar in all the organs considered. In the mammary gland, lung, spleen, small intestine and stomach the O6-meG/7-meG ratio was close to 0.11. At a lower dose of PCZ (26 mg/rat), the levels of 7-meG in the tissues were 40-60% of those produced by the higher dose. Eighty percent of the rats given the higher dose versus 37% of those given the lower dose developed mammary tumors after 20 weeks. With the higher dose of MNU (50 mg/kg body wt) DNA methylation was more or less uniform in all the organs including the mammary gland, with slightly greater yields in the liver. At a lower MNU dose (25 mg/kg) the levels of 7-meG were 40-48% of those produced by the higher dose. Fifty seven percent of the rats given the higher dose versus 21% of the animals given the lower dose developed mammary gland tumors after 20 weeks. On a mol/kg body wt basis, PCZ was approximately 5-times less active than MNU in the production of 7-meG in mammary gland but only approximately 2-times less active than MNU in the production of mammary gland tumors. The O6-alkylguanine-DNA alkyltransferase (AGT) levels in the liver, kidney, spleen and lung of PCZ or MNU treated rats were approximately 9-28% (expressed relative to protein content) and 10-33% (expressed relative to homogenate DNA content) of those in the corresponding organs of the saline-treated controls. However, the AGT levels of the mammary gland and brain were in the range of 45-61% (expressed relative to protein content) and 39-54% (expressed relative to homogenate DNA content) of those of the saline-treated controls. Also the mammary gland of the 50 day old female rats has the lowest AGT activity (expressed relative to DNA content).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311184     DOI: 10.1093/carcin/11.3.411

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

1.  DNA strand breaks and death of thymocytes induced by N-methyl-N-nitrosourea.

Authors:  T Ogiu; H Fukami; M Nishimura
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Fast repair of O6-ethylguanine, but not O6-methylguanine, in transcribed genes prevents mutation of H-ras in rat mammary tumorigenesis induced by ethylnitrosourea in place of methylnitrosourea.

Authors:  J Engelbergs; J Thomale; A Galhoff; M F Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

3.  Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk.

Authors:  Genevieve M Monsees; Peter Kraft; Stephen J Chanock; David J Hunter; Jiali Han
Journal:  Breast Cancer Res Treat       Date:  2010-05-23       Impact factor: 4.872

4.  Unique tissue-specific level of DNA nucleotide excision repair in primary human mammary epithelial cultures.

Authors:  Jean J Latimer; Tariq Nazir; Lisa C Flowers; Michael J Forlenza; Kelly Beaudry-Rodgers; Crystal M Kelly; Julie A Conte; Kenneth Shestak; Amal Kanbour-Shakir; Stephen G Grant
Journal:  Exp Cell Res       Date:  2003-11-15       Impact factor: 3.905

5.  Mutagenesis by O6 meG residues within codon 12 of the human Ha-ras proto-oncogene in monkey cells.

Authors:  V Pletsa; A Gentil; A Margot; J Armier; S A Kyrtopoulos; A Sarasin
Journal:  Nucleic Acids Res       Date:  1992-09-25       Impact factor: 16.971

6.  Ha-ras oncogene activation in mammary glands of N-methyl-N-nitrosourea-treated rats genetically resistant to mammary adenocarcinogenesis.

Authors:  S J Lu; M C Archer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

7.  Accumulation of O6-methylguanine in human DNA after therapeutic exposure to methylating agents and its relationship with biological effects.

Authors:  S A Kyrtopoulos; V L Souliotis; C Valavanis; V A Boussiotis; G A Pangalis
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

8.  Development of a 32P-postlabeling assay for 7-methylguanines in human DNA.

Authors:  R Mustonen; A Försti; P Hietanen; K Hemminki
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

9.  Formation and loss of O6-methyldeoxyguanosine in human leucocyte DNA following sequential DTIC and fotemustine chemotherapy.

Authors:  S M Lee; G P Margison; N Thatcher; P J O'Connor; D P Cooper
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.